Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind studyResearch in context

Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind studyResearch in context

Summary: Background: Previous studies have demonstrated the tolerability and efficacy of multimatrix mesalamine in inducing and maintaining remission in adults with mild-to-moderate ulcerative colitis (UC). We evaluated the safety and efficacy of low-dose and high-dose once-daily multimatrix mesala...

Full description

Bibliographic Details
Main Authors: Nicholas Michael Croft, Bartosz Korczowski, Jarosław Kierkuś, Beatriz Caballero, Manoj Kumar Thakur
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:EClinicalMedicine
Subjects:
Efficacy
Mild-to-moderate ulcerative colitis
Multimatrix mesalamine
Paediatric
Phase 3 study
Safety
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023004091

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023004091

Similar Items